@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:4365_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Medicamentos que se unen a receptores beta adrenérgicos, pero no los activan y así bloquean la acción de agonistas beta adrenérgicos. Los antagonistas beta adrenérgicos se usan en el tratamiento de la hipertensión, arritmias cardíacas, angina pectoris, glaucoma, migrañas y ansiedad."@es, "Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrythmias, angina pectoris, glaucoma, migraine headaches, and anxiety."@en ;
  dc:source "Medical Subject Headings" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:4365
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2006-01-19"^^xsd:date ;
  dc:modified "2016-06-30"^^xsd:date ;
  skos:altLabel "beta-blockers"@en, "adrenergic beta-antagonists"@en ;
  skos:broader nalt:4361 ;
  skos:definition nalt:4365_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "beta-adrenergic antagonists"@en, "antagonistas beta adrenérgicos"@es ;
  ns0:marc001 "4868" .

nalt:4361
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:4365 ;
  skos:prefLabel "antagonistas adrenérgicos"@es, "adrenergic antagonists"@en .